LG Life Sciences to Invest 100 Bil. Won in Osong
LG Life Sciences to Invest 100 Bil. Won in Osong
  • Korea IT Times
  • 승인 2015.06.13 01:36
  • 댓글 0
이 기사를 공유합니다

LG Life Sciences plans to invest 100 billion won in the Osong Life Science Complex in Cheongju, North Chungcheong Province, starting from this year until 2020.

On June 11, LG Life Sciences signed a memorandum with the North Chungcheong provincial government and the Cheongju city government to expand its vaccine-related production facilities.

LG Life Sciences has made a two-stage investment of up to 200 billion won from April 2009 to this year to set up a pharmaceutical plant in this area.

The phase-three construction, which will begin from the latter half of this year, will focus on establishing a vaccine production capacity with an total floor area of 18,744 square meters.

Once the plant enters full-scale operations, the provincial government expects it to create 100 jobs within the region. Lee Si-Jong, governor of North Chungcheong Province, said, “Once a small, remote village, Osong has become Korea’s leading biotech hub which provides extensive support for the entire R&D spectrum of the industry.”

삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • URL: www.koreaittimes.com / m.koreaittimes.com. Editorial Div. 02-578-0434 / 010-2442-9446. Email: info@koreaittimes.com.
  • Publisher: Monica Younsoo Chung. Chief Editorial Writer: Kim Hyoung-joong. CEO: Lee Kap-soo. Editor: Jung Yeon-jin.
  • Juvenile Protection Manager: Yeon Choul-woong. IT Times Canada: Willow St. Vancouver BC, Canada / 070-7008-0005.
  • Copyright(C) Korea IT Times, Allrights reserved.